The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Transforming Diabetes Care Through Artificial Intelligence: The Future Is Here
Open accessAbstract
An estimated 425 million people globally have diabetes, accounting for 12% of the world's health expenditures, and yet 1 in 2 persons remain undiagnosed and untreated. Applications of artificial intelligence (AI) and cognitive computing offer promise in diabetes care. The purpose of this article is to better understand what AI advances may be relevant today to persons with diabetes (PWDs), their clinicians, family, and caregivers. The authors conducted a predefined, online PubMed search of publicly available sources of information from 2009 onward using the search terms “diabetes” and “artificial intelligence.” The study included clinically-relevant, high-impact articles, and excluded articles whose purpose was technical in nature. A total of 450 published diabetes and AI articles met the inclusion criteria. The studies represent a diverse and complex set of innovative approaches that aim to transform diabetes care in 4 main areas: automated retinal screening, clinical decision support, predictive population risk stratification, and patient self-management tools. Many of these new AI-powered retinal imaging systems, predictive modeling programs, glucose sensors, insulin pumps, smartphone applications, and other decision-support aids are on the market today with more on the way. AI applications have the potential to transform diabetes care and help millions of PWDs to achieve better blood glucose control, reduce hypoglycemic episodes, and reduce diabetes comorbidities and complications. AI applications offer greater accuracy, efficiency, ease of use, and satisfaction for PWDs, their clinicians, family, and caregivers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AI models have already begun to revolutionize how new drugs are identified and developed, and their applications in diabetes therapeutics are particularly promising (114).”
From Generative artificial intelligence in predictive analysis of diabetes and its complications: a narrative review (2025) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, several studies have shown improved diagnostic accuracy, patient triage, and clerical burden reduction.10,11”
From Clinician Adoption of an Artificial Intelligence Algorithm to Detect Left Ventricular Systolic Dysfunction in Primary Care. (2022) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Gulshan, V., Peng, L., Coram, M., Stumpe, M. C., Wu, D., Narayanaswamy, A., Venugopalan, S., Widner, K., Madams, T., Cuadros, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.17216 · Cited by 7,697
Big data analytics in healthcare: promise and potential
Raghupathi, W., & Raghupathi, V. (2014) · Health Information Science and Systems · doi:10.1186/2047-2501-2-3 · Cited by 3,034
Home Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Electronic Health Record Adoption In US Hospitals: Progress Continues, But Challenges Persist
Adler-Milstein, J., DesRoches, C. M., Kralovec, P., Foster, G., Worzala, C., Charles, D., Searcy, T., & Jha, A. K. (2015) · Health Affairs · doi:10.1377/hlthaff.2015.0992 · Cited by 310
Vijan, S. (2000) · JAMA · doi:10.1001/jama.283.7.889 · Cited by 295
Principles of Health Interoperability HL7 and SNOMED
Benson, T. (2012) · Health information technology standards · doi:10.1007/978-1-4471-2801-4 · Cited by 242
Keel, S., Lee, P. Y., Scheetz, J., Li, Z., Kotowicz, M. A., MacIsaac, R. J., & He, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-22612-2 · Cited by 220
Retinal Lesion Detection With Deep Learning Using Image Patches
Lam, C., Yu, C., Huang, L. C., & Rubin, D. L. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22721 · Cited by 212
Research works printed but not linked: 6
- International Diabetes Federation (IDF). IDF diabetes atlas 7th edition. Brussels Belgium: International Diabetes Federation 2015.
- Latts L. ADA/IBM Watson Health Study (N>300,000) finds that nearly 60% of people with T2D discontinue therapy after one year. Presented at: American Diabetes Association 78th Scientific Session, June 22–26, 2018, Orlando, FL.
- National Center for Biotechnology Information; US National Library of Medicine. PubMed. https://www.ncbi.nlm.nih.gov/pubmed/ Accessed July18 2018.
- Aggarwal M Madhukar M. IBM's Watson analytics for health care: a miracle made true. Hershey PA: IGI Global 2016:117–134. · DOI
- Neemuchwala H. Sugar.IQ improves time-in-range by 36 mins/day, time >180 by 30 mins/day, time <70 by 6 mins/day. Presented at: American Diabetes Association 78th Scientific Session, June 22–26, 2018, Orlando, FL.
- Hutson TM. Missing data hinder replication of artificial intelligence studies. www.sciencemag.org/news/2018/02/missing-data-hinder-replication-artificial-intelligence-studies? Accessed July18 2018. · DOI
Cited by
Sorted by citations
Artificial Intelligence: The Future for Diabetes Care
Ellahham, S. H. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.03.033 · Cited by 404
Deep Learning for Diabetes: A Systematic Review
Zhu, T., Li, K., Herrero, P., & Georgiou, P. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.3040225 · Cited by 290
Prediction of Type 2 Diabetes Based on Machine Learning Algorithm
Deberneh, H. M., & Kim, I. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18063317 · Cited by 261
Makino, M., Yoshimoto, R., Ono, M., Itoko, T., Katsuki, T., Koseki, A., Kudo, M., Haida, K., Kuroda, J., Yanagiya, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48263-5 · Cited by 250
A Brief Survey on Breast Cancer Diagnostic With Deep Learning Schemes Using Multi-Image Modalities
Mahmood, T., Li, J., Pei, Y., Akhtar, F., Imran, A., & Rehman, K. U. (2020) · IEEE Access · doi:10.1109/access.2020.3021343 · Cited by 187
Metadata
- Authors
- Dankwa-Mullan, I., Rivo, M., Sepulveda, M., Park, Y., Snowdon, J., & Rhee, K.
- Affiliations
- IBM Corporation, Watson Health, Bethesda, Maryland.
- Population Health Innovations, Inc., Miami Beach, Florida.
- University of Iowa (US)
- IBM Research - Cambridge (United States) (US)
- IBM (United States) (US)
- Corresponding author
- Rivo, Marc
- Venue
- Population Health Management
- Publisher
- SAGE Publications
- Published
- 2019-05-30
- Volume
- 22
- Issue
- 3
- Pages
- 229-242
- ISSN
- 1942-7891 (ISSN-L)
- 1942-7905
- PMC
- PMC6555175
- OpenAlex
- W2893457521
- Cited by
- 217
- References
- 39
- Citations by year
- 2026: 19 · 2025: 32 · 2024: 38 · 2023: 35 · 2022: 32 · 2021: 20 · 2020: 32 · 2019: 7
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Population Health Management (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Keywords
- artificial intelligence, diabetes management, automated retinal screening, clinical decision support, diabetes risk stratification, predictive modeling, patient self-management, glucose monitoring, insulin pump, mobile application, glycemic control, hypoglycemia, diabetes complications, cognitive computing
- MeSH terms
- Self-Management, Artificial Intelligence, Decision Support Techniques, Diabetes Mellitus, Forecasting, Humans, Retina, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
